Poxel (XPAR:POXEL) Net Issuance of Preferred Stock : €0.00 Mil (TTM As of Dec. 2022)

View and export this data going back to 2015. Start your Free Trial

What is Poxel Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Poxel's net issuance of preferred for the six months ended in Dec. 2022 was €0.00 Mil. The number is 0, which means that Poxel has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Poxel's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2022 was €0.00 Mil.

Poxel Net Issuance of Preferred Stock Historical Data

The historical data trend for Poxel's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poxel Net Issuance of Preferred Stock Chart

Poxel Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Poxel Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Poxel Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Poxel Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Poxel's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Poxel (XPAR:POXEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (XPAR:POXEL) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007

Website

https://www.poxel.com

Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.

Poxel (XPAR:POXEL) Headlines

No Headlines